Načítá se...
Progress in the development of virus-like particle vaccines against respiratory viruses
Introduction: Influenza virus, human respiratory syncytial virus (RSV), and human metapneumovirus (HMPV) are important human respiratory pathogens. Recombinant virus-like particle (VLP) vaccines are suggested to be potential promising platforms to protect against these respiratory viruses. This revi...
Uloženo v:
| Vydáno v: | Expert Rev Vaccines |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103727/ https://ncbi.nlm.nih.gov/pubmed/31903811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14760584.2020.1711053 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|